EP Patent

EP2986623A4 — C3,3-DISUBSTITUTED 19-NOR-C21-N-PYRAZOLYL-STEROIDS AND METHODS OF USE THEREOF

Assigned to Sage Therapeutics Inc · Expires 2016-09-28 · 10y expired

What this patent protects

Patent listed against Zurzuvae.

Drugs covered by this patent

Patent Metadata

Patent number
EP2986623A4
Jurisdiction
EP
Classification
—
Expires
2016-09-28
Drug substance claim
No
Drug product claim
No
Assignee
Sage Therapeutics Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.